Human Blood-derived Mesenchymal Stem Cell to Repair Cartilage Defect

1. Technology Overview

The present invention provides a method of isolating, culturing, proliferating and maintenance of the mesenchymal stem cells (MSCs) derived from human peripheral blood. The peripheral blood is a (clinically accessible) potential sources of MSCs. The method used in the present invention is reliable, involved minimal invasive procedure, less time and cost consuming. MSCs is able to isolate, purify, greatly multiply and differentiate into cartilage cells for the use of treating cartilage defect. Thus, the present invention also provides a potential cell therapy to repair cartilage defects from the human blood-derived chondrogenesis-MSCs

  • UMCIC File Number: 628/204
  • Patent: MY-157059-A
  • Patent status: Granted
  • Malaysia patent: Human Blood-derived Mesenchymal Stem Cell to Repair Cartilage Defect
  • This technology is currently available for licensing and commercialisation.

 

For a more https://schreib-essay.com exacting style for academic writing in the social sciences, many american universities recommend or require apa style your name, class, university, other information if you want